April 24, 2014 6:54 PM ET

Capital Markets

Company Overview of Alston Capital Partners

Executive Profile

Stephen W. Sanger

Independent Director, Chairman of Corporate Governance Committee, Member of Audit Committee and Member of Science & Technology Committee, Pfizer Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 7 different industries.

See Board Relationships
67$300,000

Background

Mr. Stephen W. Sanger, also known as Steve, has been Director of Wells Fargo & Company of Wells Fargo Capital Finance, Inc. since July 22, 2003 and has been its Lead Director since January 1, 2012. He has been an Independent Director of Pfizer Inc. since February 3, 2009 and Target Corp., since 1996. He serves as a Director of General Mills Operations Inc. He serves as a Member of the Board of Advisors at the Retail Food Industry Center. He was an Advisor at Alston Capital ...

Corporate Headquarters

551 Fifth Avenue
New York, New York 10176

United States

Phone: --
Fax: --

Board Members Memberships

Director
Former Director
1992-2003
Former Director
1992-2008
Former Chairman
1996-N/A
Former Independent Director, Chairman of Nominating & Governance Committee and Member of Compensation Committee
2003-Present
Lead Director, Chairman of Governance & Nominating Committee, Member of Human Resources Committee and Member of Risk Committee
2009-Present
Independent Director, Chairman of Corporate Governance Committee, Member of Audit Committee and Member of Science & Technology Committee

Education

MBA 1970
University of Michigan
Bachelor's Degree 1968
DePauw University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$162,500
Total Calculated Compensation$300,000
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
$2.9M
Kenneth C. Frazier Chairman and Chief Executive Officer
Merck & Co. Inc.
$1.5M
Joseph Jimenez MBAChief Executive Officer and Member of Executive Committee
Novartis AG
$3.1M
Christopher A. Viehbacher Chief Executive Officer, Director and Member of Strategy Committee
Sanofi
$3.0M
Severin Schwan Ph.D.Chief Executive Officer and Director
Roche Holding AG
$5.1M
Compensation as of Fiscal Year 2013.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Alston Capital Partners, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.